Pay in 4 interest-free payments of $6.85 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
The weight-loss war just entered its most convenient phase
Pack them in their original container with your prescription label and you are ready to go
Available from: Cataldi M, Muscogiuri G, Savastano S, et al
Key features: triple agonist GLP-1 / GIP / glucagon recep Route: subcutaneous injection (weekly protocols) Indications: management of obesity and weight reduction Expected effects: strong appetite reduction, loss of fat mass, metabolic improvement (insulin sensitivity), increased energy metabolism Customer benefits: Substantial weight loss, potentially greater than current agents Improvement in metabolic parameters associated with obesity Potential improvement in quality of life related to weight reduction
However, this needs further study
When the medicine is eventually approved, prescribers will follow the MHRA-approved Summary of Product Characteristics
US$ 22.30
US$ 23.22
US$ 21.73
